(+)-dexrazoxane increases expression ISO RGD:732766 6480464 Dexrazoxane results in increased expression of OGG1 mRNA CTD PMID:28973540 (+)-dexrazoxane multiple interactions ISO RGD:732766 6480464 Dexrazoxane inhibits the reaction [Idarubicin results in decreased expression of OGG1 mRNA], Dexrazoxane inhibits the reaction [Idarubicin results in decreased expression of OGG1 protein] CTD PMID:28973540 (+)-pilocarpine decreases expression ISO RGD:621168 6480464 Pilocarpine results in decreased expression of OGG1 mRNA, Pilocarpine results in decreased expression of OGG1 protein CTD PMID:20206232 (S)-nicotine multiple interactions EXP 6480464 OGG1 gene SNP affects the susceptibility to [Pesticides co-treated with Nicotine] CTD PMID:29747151 1,1'-azobis(N,N-dimethylformamide) multiple interactions EXP 6480464 Diamide results in increased oxidation of and results in decreased activity of OGG1 protein CTD PMID:16923968 1,2-dimethylhydrazine decreases expression ISO RGD:621168 6480464 1, 2-Dimethylhydrazine results in decreased expression of OGG1 mRNA CTD PMID:32387197 1,4-benzoquinone decreases expression ISO RGD:732766 6480464 quinone results in decreased expression of OGG1 mRNA CTD PMID:26456483 17beta-estradiol decreases expression ISO RGD:621168 6480464 Estradiol results in decreased expression of OGG1 mRNA, Estradiol results in decreased expression of OGG1 protein CTD PMID:24894866 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of OGG1 mRNA CTD PMID:22082530 17beta-estradiol multiple interactions EXP 6480464 [Estradiol results in increased expression of OGG1 mRNA] which results in increased susceptibility to Cisplatin more ... CTD PMID:22082530 , PMID:28323900 17beta-estradiol multiple interactions ISO RGD:621168 6480464 resveratrol inhibits the reaction [Estradiol results in decreased expression of OGG1 mRNA], resveratrol inhibits the reaction [Estradiol results in decreased expression of OGG1 protein] CTD PMID:24894866 1H-pyrazole increases expression ISO RGD:732766 6480464 pyrazole results in increased expression of OGG1 mRNA CTD PMID:17945193 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732766 6480464 Tetrachlorodibenzodioxin results in decreased expression of OGG1 mRNA CTD PMID:21354282 2,4-dinitrotoluene affects expression ISO RGD:621168 6480464 2, 4-dinitrotoluene affects the expression of OGG1 mRNA CTD PMID:21346803 2,6-diamino-5-formamido-4-hydroxypyrimidine affects metabolic processing ISO RGD:732766 6480464 OGG1 protein affects the metabolism of 2, 6-diamino-4-hydroxy-5-formamidopyrimidine CTD PMID:20067321 3,4-methylenedioxymethamphetamine increases response to substance ISO RGD:732766 6480464 OGG1 gene mutant form results in increased susceptibility to N-Methyl-3, 4-methylenedioxyamphetamine CTD PMID:26629949 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of OGG1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of OGG1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of OGG1 mRNA CTD PMID:28628672 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of OGG1 mRNA CTD PMID:22082530 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 Decitabine affects the reaction [Estradiol affects the expression of OGG1 mRNA] more ... CTD PMID:22082530 , PMID:22112500 5-azacytidine decreases expression ISO RGD:732766 6480464 Azacitidine results in decreased expression of OGG1 protein CTD PMID:22064374 5-azacytidine decreases methylation ISO RGD:732766 6480464 Azacitidine results in decreased methylation of OGG1 promoter CTD PMID:22064374 6-propyl-2-thiouracil increases expression ISO RGD:621168 6480464 Propylthiouracil results in increased expression of OGG1 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:25697376 7,12-dimethyltetraphene multiple interactions EXP 6480464 Metformin inhibits the reaction [9 more ... CTD PMID:25697376 7,8-dihydro-8-oxoguanine decreases abundance EXP 6480464 OGG1 protein results in decreased abundance of 7 more ... CTD PMID:21873502 , PMID:21925250 7,8-dihydro-8-oxoguanine multiple interactions ISO RGD:732766 6480464 OGG1 protein affects the reaction [Methamphetamine results in increased abundance of 7, 8-dihydro-8-oxoguanine] CTD PMID:18768699 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO RGD:732766 6480464 NLRP3 gene mutant form inhibits the reaction [Uric Acid results in decreased expression of OGG1 mRNA] CTD PMID:23619996 7,9-dihydro-1H-purine-2,6,8(3H)-trione decreases expression ISO RGD:732766 6480464 Uric Acid results in decreased expression of OGG1 mRNA CTD PMID:23619996 8-hydroxy-2'-deoxyguanosine increases cleavage EXP 6480464 OGG1 protein results in increased cleavage of 8-Hydroxy-2'-Deoxyguanosine CTD PMID:19193190 8-hydroxy-2'-deoxyguanosine multiple interactions EXP 6480464 thymidine glycol inhibits the reaction [OGG1 protein results in increased cleavage of 8-Hydroxy-2'-Deoxyguanosine], thymidine glycol promotes the reaction [OGG1 protein results in increased cleavage of 8-Hydroxy-2'-Deoxyguanosine] CTD PMID:19193190 acrolein affects response to substance ISO RGD:732766 6480464 OGG1 protein affects the susceptibility to Acrolein CTD PMID:17003489 acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of OGG1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of OGG1 mRNA CTD PMID:32699268 acrylamide increases expression ISO RGD:621168 6480464 Acrylamide results in increased expression of OGG1 mRNA CTD PMID:28959563 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of OGG1 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:732766 6480464 Aflatoxin B1 results in increased expression of OGG1 protein CTD PMID:24675474 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of OGG1 mRNA CTD PMID:15498508 alpha-hexachlorocyclohexane multiple interactions ISO RGD:621168 6480464 [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased expression of OGG1 mRNA CTD PMID:16246485 alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of OGG1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of OGG1 mRNA CTD PMID:32699268 ammonium chloride affects expression ISO RGD:621168 6480464 Ammonium Chloride affects the expression of OGG1 mRNA CTD PMID:16483693 aniline increases expression ISO RGD:621168 6480464 aniline results in increased expression of OGG1 CTD PMID:21145906 , PMID:23352893 antirheumatic drug increases expression EXP 6480464 Antirheumatic Agents results in increased expression of OGG1 mRNA CTD PMID:24449571 aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of OGG1 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:732766 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of OGG1 mRNA CTD PMID:25113976 arsane increases expression EXP 6480464 Arsenic results in increased expression of OGG1 mRNA, Arsenic results in increased expression of OGG1 protein CTD PMID:16759981 , PMID:21332098 arsane multiple interactions ISO RGD:621168 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of OGG1 mRNA CTD PMID:31542844 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of OGG1 mRNA, Arsenic results in decreased expression of OGG1 protein CTD PMID:20478284 , PMID:35490796 arsane multiple interactions EXP 6480464 [Selenium co-treated with Arsenic] results in increased expression of OGG1 protein more ... CTD PMID:20478284 more ... arsane increases expression ISO RGD:732766 6480464 Arsenic results in increased expression of OGG1 mRNA CTD PMID:22641096 arsane affects expression EXP 6480464 Arsenic affects the expression of OGG1 CTD PMID:21235219 arsenic atom increases expression ISO RGD:732766 6480464 Arsenic results in increased expression of OGG1 mRNA CTD PMID:22641096 arsenic atom multiple interactions ISO RGD:621168 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of OGG1 mRNA CTD PMID:31542844 arsenic atom multiple interactions EXP 6480464 [Selenium co-treated with Arsenic] results in increased expression of OGG1 protein more ... CTD PMID:20478284 more ... arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of OGG1 mRNA, Arsenic results in increased expression of OGG1 protein CTD PMID:16759981 , PMID:21332098 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of OGG1 mRNA, Arsenic results in decreased expression of OGG1 protein CTD PMID:20478284 , PMID:35490796 arsenic atom affects expression EXP 6480464 Arsenic affects the expression of OGG1 CTD PMID:21235219 arsenite(3-) increases response to substance ISO RGD:732766 6480464 OGG1 gene mutant form results in increased susceptibility to arsenite CTD PMID:24190502 arsenous acid affects activity EXP 6480464 OGG1 protein affects the activity of Arsenic Trioxide CTD PMID:17101720 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of OGG1 mRNA CTD PMID:20458559 aurintricarboxylic acid decreases activity EXP 6480464 Aurintricarboxylic Acid results in decreased activity of OGG1 protein CTD PMID:26218629 belinostat decreases expression ISO RGD:732766 6480464 belinostat results in decreased expression of OGG1 mRNA, belinostat results in decreased expression of OGG1 protein CTD PMID:29733868 benzene increases response to substance EXP 6480464 OGG1 gene SNP results in increased susceptibility to Benzene CTD PMID:16600130 benzo[a]pyrene increases expression ISO RGD:732766 6480464 Benzo(a)pyrene results in increased expression of OGG1 mRNA CTD PMID:29145655 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of OGG1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of OGG1 mRNA CTD PMID:26238291 benzo[a]pyrene decreases expression ISO RGD:732766 6480464 Benzo(a)pyrene results in decreased expression of OGG1 protein CTD PMID:29145655 beryllium dichloride affects expression ISO RGD:732766 6480464 beryllium chloride affects the expression of OGG1 mRNA CTD PMID:23793613 bezafibrate increases expression ISO RGD:732766 6480464 Bezafibrate results in increased expression of OGG1 mRNA CTD PMID:15447978 biphenyl-4-amine decreases expression EXP 6480464 4-biphenylamine results in decreased expression of OGG1 mRNA, 4-biphenylamine results in decreased expression of OGG1 protein CTD PMID:16112689 , PMID:33847444 biphenyl-4-amine multiple interactions EXP 6480464 Propolis inhibits the reaction [4-biphenylamine results in decreased expression of OGG1 protein] CTD PMID:33847444 bisphenol A affects expression ISO RGD:621168 6480464 bisphenol A affects the expression of OGG1 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:621168 6480464 [bisphenol A co-treated with tributyltin] results in decreased expression of OGG1 mRNA CTD PMID:31129395 bisphenol A decreases expression ISO RGD:621168 6480464 bisphenol A results in decreased expression of OGG1 mRNA CTD PMID:30816183 more ... bisphenol F multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of OGG1 mRNA CTD PMID:28628672 bleomycin A2 affects response to substance ISO RGD:732766 6480464 OGG1 protein affects the susceptibility to Bleomycin CTD PMID:35654123 bleomycin A2 increases expression ISO RGD:732766 6480464 Bleomycin results in increased expression of OGG1 protein CTD PMID:35654123 bleomycin A2 multiple interactions ISO RGD:732766 6480464 OGG1 protein affects the reaction [Bleomycin results in decreased expression of CDH1 protein] more ... CTD PMID:35654123 C60 fullerene increases expression ISO RGD:621168 6480464 fullerene C60 results in increased expression of OGG1 mRNA CTD PMID:19479010 cadmium atom multiple interactions EXP 6480464 [Cadmium inhibits the reaction [SP1 protein binds to OGG1 promoter]] which results in decreased expression of OGG1 mRNA more ... CTD PMID:15760895 , PMID:16923968 cadmium atom affects activity EXP 6480464 Cadmium affects the activity of OGG1 protein CTD PMID:21605570 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of OGG1 mRNA, Cadmium results in decreased expression of OGG1 protein CTD PMID:15760895 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride co-treated with titanium dioxide] results in increased expression of OGG1 mRNA more ... CTD PMID:21671166 , PMID:22112500 cadmium dichloride increases expression ISO RGD:621168 6480464 Cadmium Chloride results in increased expression of OGG1 mRNA CTD PMID:30606898 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of OGG1 mRNA, Cadmium Chloride results in decreased expression of OGG1 protein CTD PMID:22112500 , PMID:26472689 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of OGG1 promoter CTD PMID:22112500 camphene multiple interactions ISO RGD:621168 6480464 [camphene co-treated with geraniol] inhibits the reaction [nimesulide results in increased expression of OGG1 protein] CTD PMID:22509279 carbon atom increases expression ISO RGD:732766 6480464 Carbon analog results in increased expression of OGG1 mRNA CTD PMID:24792328 carbon atom multiple interactions ISO RGD:732766 6480464 NCF1 gene mutant form inhibits the reaction [Carbon analog results in increased expression of OGG1 mRNA] CTD PMID:24792328 carmustine decreases response to substance EXP 6480464 OGG1 protein results in decreased susceptibility to Carmustine CTD PMID:11181913 , PMID:11741815 CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to OGG1 gene] CTD PMID:28238834 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of OGG1 protein CTD PMID:28887667 chlorpyrifos affects activity EXP 6480464 Chlorpyrifos affects the activity of OGG1 protein CTD PMID:29359425 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of OGG1 mRNA, Chlorpyrifos results in increased expression of OGG1 protein CTD PMID:29359425 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of OGG1 mRNA CTD PMID:28887667 chromium atom decreases expression EXP 6480464 Chromium results in decreased expression of OGG1 mRNA CTD PMID:30496737 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of OGG1 mRNA, chromium hexavalent ion affects the expression of OGG1 protein CTD PMID:23050433 chromium(6+) decreases expression EXP 6480464 chromium hexavalent ion results in decreased expression of OGG1 mRNA CTD PMID:30496737 cisplatin multiple interactions EXP 6480464 [Estradiol results in increased expression of OGG1 mRNA] which results in increased susceptibility to Cisplatin CTD PMID:28323900 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of OGG1 mRNA CTD PMID:19320972 crocidolite asbestos increases expression EXP 6480464 Asbestos, Crocidolite results in increased expression of OGG1 mRNA CTD PMID:11181447 crocidolite asbestos multiple interactions ISO RGD:732766 6480464 OGG1 protein mutant form promotes the reaction [Asbestos more ... CTD PMID:24918270 crocidolite asbestos increases response to substance ISO RGD:732766 6480464 OGG1 protein mutant form results in increased susceptibility to Asbestos, Crocidolite CTD PMID:24918270 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Arsenic results in increased expression of OGG1 mRNA], Curcumin inhibits the reaction [Arsenic results in increased expression of OGG1 protein] CTD PMID:21332098 cyclophosphamide decreases expression ISO RGD:732766 6480464 Cyclophosphamide results in decreased expression of OGG1 protein CTD PMID:27032448 DDT multiple interactions ISO RGD:621168 6480464 [DDT co-treated with Diethylnitrosamine] results in decreased expression of OGG1 mRNA, [DDT co-treated with Diethylnitrosamine] results in increased expression of OGG1 mRNA CTD PMID:15885732 DDT increases expression ISO RGD:621168 6480464 DDT results in increased expression of OGG1 mRNA CTD PMID:11948501 deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of OGG1 mRNA, deoxynivalenol results in increased expression of OGG1 protein CTD PMID:24355168 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of OGG1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of OGG1 mRNA CTD PMID:28628672 Diacetoxyscirpenol decreases expression ISO RGD:732766 6480464 diacetoxyscirpenol results in decreased expression of OGG1 mRNA CTD PMID:31836554 diarsenic trioxide affects activity EXP 6480464 OGG1 protein affects the activity of Arsenic Trioxide CTD PMID:17101720 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of OGG1 mRNA CTD PMID:20458559 diethyl maleate multiple interactions ISO RGD:732766 6480464 [diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of OGG1 mRNA CTD PMID:22564015 dimethylarsinic acid multiple interactions ISO RGD:732766 6480464 OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA1B mRNA] more ... CTD PMID:17441966 dimethylarsinic acid increases expression ISO RGD:621168 6480464 Cacodylic Acid results in increased expression of OGG1 mRNA CTD PMID:17481689 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of OGG1 protein CTD PMID:25030372 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OGG1 mRNA CTD PMID:27188386 doxorubicin multiple interactions EXP 6480464 [Estradiol results in increased expression of OGG1 mRNA] which results in increased susceptibility to Doxorubicin CTD PMID:28323900 elemental carbon increases expression ISO RGD:732766 6480464 Carbon analog results in increased expression of OGG1 mRNA CTD PMID:24792328 elemental carbon multiple interactions ISO RGD:732766 6480464 NCF1 gene mutant form inhibits the reaction [Carbon analog results in increased expression of OGG1 mRNA] CTD PMID:24792328 elemental selenium multiple interactions EXP 6480464 [Selenium co-treated with Arsenic] results in increased expression of OGG1 protein CTD PMID:20478284 elemental selenium increases expression EXP 6480464 Selenium results in increased expression of OGG1 protein CTD PMID:20478284 entinostat decreases expression EXP 6480464 entinostat results in decreased expression of OGG1 mRNA CTD PMID:26272509 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OGG1 mRNA CTD PMID:27188386 ethanol increases expression EXP 6480464 Ethanol results in increased expression of OGG1 mRNA, Ethanol results in increased expression of OGG1 protein CTD PMID:22056336 ethanol multiple interactions ISO RGD:732766 6480464 phenyl-N-tert-butylnitrone inhibits the reaction [OGG1 mutant form results in increased susceptibility to Ethanol] CTD PMID:25354798 ethanol increases response to substance ISO RGD:732766 6480464 OGG1 mutant form results in increased susceptibility to Ethanol CTD PMID:25354798 etoposide multiple interactions ISO RGD:732766 6480464 wogonin inhibits the reaction [Etoposide results in decreased expression of OGG1 mRNA] CTD PMID:23872129 etoposide decreases expression ISO RGD:732766 6480464 Etoposide results in decreased expression of OGG1 mRNA CTD PMID:23872129 flutamide increases expression ISO RGD:621168 6480464 Flutamide results in increased expression of OGG1 mRNA CTD PMID:24793618 folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Arsenic results in decreased expression of OGG1 mRNA] CTD PMID:35490796 furan decreases expression ISO RGD:621168 6480464 furan results in decreased expression of OGG1 mRNA CTD PMID:22507866 geraniol multiple interactions ISO RGD:621168 6480464 [camphene co-treated with geraniol] inhibits the reaction [nimesulide results in increased expression of OGG1 protein] CTD PMID:22509279 glutathione multiple interactions ISO RGD:732766 6480464 [diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of OGG1 mRNA CTD PMID:22564015 glycine betaine multiple interactions ISO RGD:732766 6480464 Betaine inhibits the reaction [S-Adenosylhomocysteine results in decreased expression of OGG1 protein], Betaine inhibits the reaction [S-Adenosylhomocysteine results in decreased methylation of OGG1 promoter] CTD PMID:22064374 glyphosate affects activity EXP 6480464 glyphosate affects the activity of OGG1 protein CTD PMID:29359425 glyphosate decreases expression EXP 6480464 glyphosate results in decreased expression of OGG1 mRNA CTD PMID:31295307 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of OGG1 mRNA, glyphosate results in increased expression of OGG1 protein CTD PMID:29359425 gold atom multiple interactions EXP 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of OGG1 mRNA CTD PMID:28433809 gold(0) multiple interactions EXP 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of OGG1 mRNA CTD PMID:28433809 hydralazine multiple interactions EXP 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of OGG1 mRNA CTD PMID:17183730 hydrazine multiple interactions ISO RGD:732766 6480464 hydrazine inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased expression of OGG1 mRNA] CTD PMID:32142722 hydrazines decreases activity EXP 6480464 Hydrazines analog results in decreased activity of OGG1 protein CTD PMID:26218629 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of OGG1 mRNA CTD PMID:19651184 hydrogen peroxide increases response to substance EXP 6480464 OGG1 mutant form results in increased susceptibility to Hydrogen Peroxide, OGG1 protein results in increased susceptibility to Hydrogen Peroxide CTD PMID:25127756 , PMID:34196753 hydrogen peroxide multiple interactions EXP 6480464 [NUDT1 mutant form results in increased susceptibility to Hydrogen Peroxide] which results in increased expression of OGG1 mRNA more ... CTD PMID:19651184 , PMID:25127756 idarubicin multiple interactions ISO RGD:732766 6480464 Dexrazoxane inhibits the reaction [Idarubicin results in decreased expression of OGG1 mRNA], Dexrazoxane inhibits the reaction [Idarubicin results in decreased expression of OGG1 protein] CTD PMID:28973540 idarubicin decreases expression ISO RGD:732766 6480464 Idarubicin results in decreased expression of OGG1 mRNA, Idarubicin results in decreased expression of OGG1 protein CTD PMID:28973540 imidacloprid increases expression ISO RGD:621168 6480464 imidacloprid results in increased expression of OGG1 mRNA CTD PMID:27914857 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of OGG1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of OGG1 mRNA CTD PMID:28628672 L-ascorbic acid multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [sodium arsenite results in decreased expression of OGG1 protein], Ascorbic Acid inhibits the reaction [sodium arsenite results in increased methylation of OGG1 promoter] CTD PMID:33388378 lead(0) decreases expression ISO RGD:732766 6480464 Lead results in decreased expression of OGG1 mRNA CTD PMID:22641096 lead(0) affects response to substance EXP 6480464 OGG1 gene polymorphism affects the susceptibility to Lead CTD PMID:22466227 lead(2+) affects response to substance EXP 6480464 OGG1 gene polymorphism affects the susceptibility to Lead CTD PMID:22466227 lead(2+) decreases expression ISO RGD:732766 6480464 Lead results in decreased expression of OGG1 mRNA CTD PMID:22641096 lithium atom decreases expression ISO RGD:732766 6480464 Lithium results in decreased expression of OGG1 mRNA CTD PMID:22641096 lithium hydride decreases expression ISO RGD:732766 6480464 Lithium results in decreased expression of OGG1 mRNA CTD PMID:22641096 lupeol multiple interactions EXP 6480464 lupeol inhibits the reaction [mancozeb results in decreased expression of OGG1 mRNA] CTD PMID:27235710 mancozeb multiple interactions EXP 6480464 lupeol inhibits the reaction [mancozeb results in decreased expression of OGG1 mRNA] CTD PMID:27235710 mancozeb decreases expression EXP 6480464 mancozeb results in decreased expression of OGG1 mRNA CTD PMID:27235710 manganese atom decreases expression ISO RGD:732766 6480464 Manganese results in decreased expression of OGG1 mRNA CTD PMID:22641096 manganese(0) decreases expression ISO RGD:732766 6480464 Manganese results in decreased expression of OGG1 mRNA CTD PMID:22641096 menadione increases response to substance EXP 6480464 OGG1 protein SNP results in increased susceptibility to Vitamin K 3 CTD PMID:17651912 menadione increases expression EXP 6480464 Vitamin K 3 results in increased expression of OGG1 mRNA CTD PMID:23410634 mercury atom decreases expression ISO RGD:732766 6480464 Mercury results in decreased expression of OGG1 mRNA CTD PMID:22641096 mercury(0) decreases expression ISO RGD:732766 6480464 Mercury results in decreased expression of OGG1 mRNA CTD PMID:22641096 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [9 more ... CTD PMID:25697376 methamphetamine multiple interactions ISO RGD:732766 6480464 OGG1 protein affects the reaction [Methamphetamine results in increased abundance of 7, 8-dihydro-8-oxoguanine] CTD PMID:18768699 methamphetamine decreases expression ISO RGD:621168 6480464 Methamphetamine results in decreased expression of OGG1 mRNA CTD PMID:19564919 methamphetamine multiple interactions ISO RGD:621168 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of OGG1 mRNA CTD PMID:19564919 methamphetamine affects response to substance ISO RGD:732766 6480464 OGG1 protein affects the susceptibility to Methamphetamine CTD PMID:18768699 methyl methanesulfonate increases response to substance EXP 6480464 OGG1 protein results in increased susceptibility to Methyl Methanesulfonate CTD PMID:34196753 methyl tert-butyl ether increases expression ISO RGD:621168 6480464 methyl tert-butyl ether results in increased expression of OGG1 mRNA CTD PMID:19150650 methylarsonic acid increases expression ISO RGD:621168 6480464 monomethylarsonic acid results in increased expression of OGG1 mRNA CTD PMID:17481689 miconazole decreases expression ISO RGD:621168 6480464 Miconazole results in decreased expression of OGG1 mRNA CTD PMID:22262564 mitomycin C decreases expression ISO RGD:732766 6480464 Mitomycin results in decreased expression of OGG1 protein CTD PMID:27032448 monocrotophos decreases expression EXP 6480464 Monocrotophos results in decreased expression of OGG1 mRNA CTD PMID:28887667 myristicin decreases expression EXP 6480464 myristicin results in decreased expression of OGG1 mRNA CTD PMID:24792648 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TH5487 inhibits the reaction [TGFB1 protein results in increased expression of OGG1 protein]], benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [TGFB1 protein results in increased expression of OGG1 protein] CTD PMID:35654123 N-nitrosodiethylamine multiple interactions ISO RGD:732766 6480464 [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of OGG1 mRNA more ... CTD PMID:20101389 more ... N-nitrosodiethylamine multiple interactions ISO RGD:621168 6480464 [DDT co-treated with Diethylnitrosamine] results in decreased expression of OGG1 mRNA more ... CTD PMID:15885732 more ... N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of OGG1 mRNA CTD PMID:19031421 nickel atom decreases expression ISO RGD:732766 6480464 Nickel results in decreased expression of OGG1 mRNA CTD PMID:22641096 nicotine multiple interactions EXP 6480464 OGG1 gene SNP affects the susceptibility to [Pesticides co-treated with Nicotine] CTD PMID:29747151 nimesulide multiple interactions ISO RGD:621168 6480464 [camphene co-treated with geraniol] inhibits the reaction [nimesulide results in increased expression of OGG1 protein], Silymarin inhibits the reaction [nimesulide results in increased expression of OGG1 protein] CTD PMID:22509279 nimesulide increases expression ISO RGD:621168 6480464 nimesulide results in increased expression of OGG1 protein CTD PMID:22509279 O-methyleugenol decreases expression ISO RGD:621168 6480464 methyleugenol results in decreased expression of OGG1 mRNA CTD PMID:21659616 ochratoxin A decreases expression ISO RGD:621168 6480464 ochratoxin A results in decreased expression of OGG1 mRNA CTD PMID:23358140 oxaliplatin multiple interactions ISO RGD:621168 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of OGG1 mRNA CTD PMID:25729387 oxirane increases expression ISO RGD:621168 6480464 Ethylene Oxide results in increased expression of OGG1 protein CTD PMID:16051529 oxirane affects response to substance EXP 6480464 OGG1 protein affects the susceptibility to Ethylene Oxide CTD PMID:16386346 ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of OGG1 mRNA more ... CTD PMID:29767793 , PMID:32699268 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of OGG1 protein CTD PMID:15907983 paracetamol affects expression ISO RGD:732766 6480464 Acetaminophen affects the expression of OGG1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of OGG1 mRNA CTD PMID:25704631 , PMID:29067470 paracetamol increases expression ISO RGD:621168 6480464 Acetaminophen results in increased expression of OGG1 mRNA CTD PMID:16751229 paracetamol multiple interactions ISO RGD:732766 6480464 O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1, 2-diolate inhibits the reaction [Acetaminophen results in increased expression of OGG1 mRNA] CTD PMID:12540782 paracetamol increases expression ISO RGD:732766 6480464 Acetaminophen results in increased expression of OGG1 mRNA CTD PMID:12540782 paraquat affects response to substance EXP 6480464 OGG1 gene SNP affects the susceptibility to Paraquat CTD PMID:28460087 paraquat decreases expression ISO RGD:621168 6480464 Paraquat results in decreased expression of OGG1 mRNA, Paraquat results in decreased expression of OGG1 protein CTD PMID:27993944 parathion-methyl increases methylation ISO RGD:732766 6480464 Methyl Parathion results in increased methylation of OGG1 promoter CTD PMID:29540303 phenobarbital decreases expression ISO RGD:621168 6480464 Phenobarbital results in decreased expression of OGG1 mRNA CTD PMID:24090815 pioglitazone multiple interactions ISO RGD:732766 6480464 Pioglitazone inhibits the reaction [LEPR protein affects the expression of OGG1 protein] CTD PMID:35472412 piperonyl butoxide multiple interactions ISO RGD:732766 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in decreased expression of OGG1 mRNA CTD PMID:20101389 pirfenidone multiple interactions ISO RGD:732766 6480464 pirfenidone inhibits the reaction [Bleomycin results in increased expression of OGG1 protein] CTD PMID:35654123 potassium bromate decreases response to substance ISO RGD:732766 6480464 OGG1 gene mutant form results in decreased susceptibility to potassium bromate CTD PMID:25693136 potassium bromate increases response to substance EXP 6480464 OGG1 protein results in increased susceptibility to potassium bromate CTD PMID:34196753 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of OGG1 mRNA CTD PMID:30496737 pristane increases response to substance ISO RGD:732766 6480464 OGG1 gene mutant form results in increased susceptibility to pristane CTD PMID:33072095 procyanidin B1 increases expression ISO RGD:732766 6480464 procyanidin B1 results in increased expression of OGG1 mRNA, procyanidin B1 results in increased expression of OGG1 protein CTD PMID:34684730 quartz decreases expression EXP 6480464 Quartz results in decreased expression of OGG1 mRNA CTD PMID:27917503 quercetin multiple interactions EXP 6480464 Quercetin promotes the reaction [Hydrogen Peroxide results in increased expression of OGG1 mRNA] CTD PMID:19651184 quercetin increases expression EXP 6480464 Quercetin results in increased expression of OGG1 mRNA CTD PMID:19651184 reactive oxygen species increases expression ISO RGD:621168 6480464 Reactive Oxygen Species results in increased expression of OGG1 mRNA CTD PMID:29085557 reactive oxygen species affects expression EXP 6480464 Reactive Oxygen Species affects the expression of OGG1 mRNA CTD PMID:25800948 resveratrol multiple interactions ISO RGD:621168 6480464 resveratrol inhibits the reaction [Estradiol results in decreased expression of OGG1 mRNA], resveratrol inhibits the reaction [Estradiol results in decreased expression of OGG1 protein] CTD PMID:24894866 resveratrol decreases expression ISO RGD:621168 6480464 Resveratrol results in decreased expression of OGG1 mRNA CTD PMID:33775663 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of OGG1 mRNA, resveratrol results in increased expression of OGG1 protein CTD PMID:22056336 resveratrol increases expression ISO RGD:621168 6480464 resveratrol results in increased expression of OGG1 mRNA, resveratrol results in increased expression of OGG1 protein CTD PMID:24894866 rosmarinic acid increases expression ISO RGD:621168 6480464 rosmarinic acid results in increased expression of OGG1 mRNA CTD PMID:18996367 S-adenosyl-L-homocysteine multiple interactions ISO RGD:732766 6480464 Betaine inhibits the reaction [S-Adenosylhomocysteine results in decreased expression of OGG1 protein] more ... CTD PMID:22064374 S-adenosyl-L-homocysteine decreases methylation ISO RGD:732766 6480464 S-Adenosylhomocysteine results in decreased methylation of OGG1 promoter CTD PMID:22064374 S-adenosyl-L-homocysteine decreases expression ISO RGD:732766 6480464 S-Adenosylhomocysteine results in decreased expression of OGG1 mRNA, S-Adenosylhomocysteine results in decreased expression of OGG1 protein CTD PMID:22064374 S-butyl-DL-homocysteine (S,R)-sulfoximine affects response to substance ISO RGD:732766 6480464 OGG1 protein affects the susceptibility to Buthionine Sulfoximine CTD PMID:32585298 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:732766 6480464 Buthionine Sulfoximine affects the reaction [OGG1 protein affects the expression of SOD2 mRNA] CTD PMID:32585298 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OGG1 mRNA CTD PMID:27188386 SCH 23390 multiple interactions ISO RGD:621168 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of OGG1 mRNA CTD PMID:19564919 selenium atom multiple interactions EXP 6480464 [Selenium co-treated with Arsenic] results in increased expression of OGG1 protein CTD PMID:20478284 selenium atom increases expression EXP 6480464 Selenium results in increased expression of OGG1 protein CTD PMID:20478284 silicon dioxide increases expression ISO RGD:621168 6480464 Silicon Dioxide results in increased expression of OGG1 protein CTD PMID:23178243 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of OGG1 mRNA CTD PMID:25351596 sodium arsenite increases methylation EXP 6480464 sodium arsenite results in increased methylation of OGG1 promoter CTD PMID:33388378 sodium arsenite multiple interactions ISO RGD:621168 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of OGG1 mRNA CTD PMID:31542844 sodium arsenite decreases expression ISO RGD:621168 6480464 sodium arsenite results in decreased expression of OGG1 protein CTD PMID:26432159 sodium arsenite increases expression ISO RGD:732766 6480464 sodium arsenite results in increased expression of OGG1 mRNA CTD PMID:20643705 sodium arsenite decreases expression ISO RGD:732766 6480464 sodium arsenite results in decreased expression of OGG1 mRNA CTD PMID:17558810 , PMID:20643705 sodium arsenite multiple interactions ISO RGD:732766 6480464 [OGG1 gene mutant form results in increased susceptibility to sodium arsenite] which affects the expression of ACTA2 mRNA more ... CTD PMID:26438402 sodium arsenite increases response to substance ISO RGD:732766 6480464 OGG1 gene mutant form results in increased susceptibility to sodium arsenite CTD PMID:26438402 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of OGG1 mRNA, sodium arsenite results in decreased expression of OGG1 protein CTD PMID:12359242 more ... sodium arsenite multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [sodium arsenite results in decreased expression of OGG1 protein] more ... CTD PMID:12359242 , PMID:33388378 sodium dichromate increases expression ISO RGD:621168 6480464 sodium bichromate results in increased expression of OGG1 mRNA CTD PMID:22561333 sodium dichromate increases response to substance EXP 6480464 OGG1 protein polymorphism results in increased susceptibility to sodium bichromate CTD PMID:15734978 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of OGG1 mRNA, sodium bichromate results in decreased expression of OGG1 protein CTD PMID:11756223 Soman decreases expression ISO RGD:621168 6480464 Soman results in decreased expression of OGG1 mRNA CTD PMID:19281266 sterigmatocystin increases expression ISO RGD:621168 6480464 Sterigmatocystin results in increased expression of OGG1 mRNA CTD PMID:34126181 styrene affects response to substance EXP 6480464 OGG1 protein polymorphism affects the susceptibility to Styrene CTD PMID:19563869 styrene increases expression EXP 6480464 Styrene results in increased expression of OGG1 mRNA CTD PMID:21030303 tamibarotene increases expression EXP 6480464 tamibarotene results in increased expression of OGG1 mRNA CTD PMID:15498508 tert-butyl ethyl ether decreases expression ISO RGD:621168 6480464 ethyl tert-butyl ether results in decreased expression of OGG1 mRNA CTD PMID:24090815 tetrachloromethane affects expression ISO RGD:732766 6480464 Carbon Tetrachloride affects the expression of OGG1 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:732766 6480464 [Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of OGG1 mRNA CTD PMID:23288052 Thiotepa decreases response to substance EXP 6480464 OGG1 protein results in decreased susceptibility to Thiotepa CTD PMID:11181913 , PMID:11431349 Thymidine glycol multiple interactions EXP 6480464 thymidine glycol inhibits the reaction [OGG1 protein results in increased cleavage of 8-Hydroxy-2'-Deoxyguanosine], thymidine glycol promotes the reaction [OGG1 protein results in increased cleavage of 8-Hydroxy-2'-Deoxyguanosine] CTD PMID:19193190 titanium dioxide multiple interactions EXP 6480464 [Cadmium Chloride co-treated with titanium dioxide] results in increased expression of OGG1 mRNA CTD PMID:21671166 topotecan multiple interactions ISO RGD:621168 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of OGG1 mRNA CTD PMID:25729387 tributylstannane multiple interactions ISO RGD:621168 6480464 [bisphenol A co-treated with tributyltin] results in decreased expression of OGG1 mRNA CTD PMID:31129395 trimethylarsine oxide increases expression ISO RGD:621168 6480464 trimethylarsine oxide results in increased expression of OGG1 mRNA CTD PMID:17481689 valproic acid multiple interactions EXP 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of OGG1 mRNA CTD PMID:17183730 vincristine decreases expression EXP 6480464 Vincristine results in decreased expression of OGG1 mRNA CTD PMID:23649840 vorinostat decreases expression ISO RGD:732766 6480464 Vorinostat results in decreased expression of OGG1 mRNA, Vorinostat results in decreased expression of OGG1 protein CTD PMID:32512035 wogonin multiple interactions ISO RGD:732766 6480464 wogonin inhibits the reaction [Etoposide results in decreased expression of OGG1 mRNA] CTD PMID:23872129